Long-term monitoring for nanomedicine implants and drugs.


The Royal Society conference Bionano Interactions: New Tools, Insights and Impacts (30 April to 1 May 2014) discussed translating potential nanobiotechnologies into clinical applications, and assessed their safety and science-based regulatory regimes1. A key topic of debate was whether nanomaterials and nanostructures require additional or alternative risk… (More)
DOI: 10.1038/nnano.2015.341

3 Figures and Tables


  • Presentations referencing similar topics